In summary, we have investigated the PSMA expression and CD8+ T-cell infiltration in primary tumour samples of PC patients from two independent cohorts and identified a patient subset with high-risk local disease or metastatic cancer that may be susceptible to T-cell engager therapy. Here, FOLH1 is linked to neoplasm.